Methylprednisolone Unknown Status Phase 2 Trials for Acute Lung Injury (ALI) / Acute Respiratory Distress Syndrome (ARDS) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01274260Trial of Steroids in Pediatric Acute Lung Injury/ARDS